CARA THERAPEUTICS INC shareholders Q2 2023

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 138 filers reported holding CARA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

CARA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
AMALGAMATED BANK 4,602$130.00%
WOLVERINE TRADING, LLC 32,200$91,7700.00%
BlackRock Inc. 3,701,968$10,476,5700.00%
Horrell Capital Management, Inc. 200$10.00%
Bank of New York Mellon Corp 189,175$535,3640.00%
LPL Financial LLC 173,144$489,9970.00%
Citadel Advisors 41,500$117,4450.00%
Citadel Advisors 9,200$26,0360.00%
Citadel Advisors 268,285$759,2470.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 500$10.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 26,300$74,4290.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 258,471$731,4720.00%
Daiwa Securities Group Inc. 172$00.00%
Nuveen Asset Management, LLC 114,384$323,7070.00%
CAPTRUST FINANCIAL ADVISORS 17,108$48,4160.00%
McIlrath & Eck, LLC 736$2,0830.00%
Steward Partners Investment Advisory, LLC 150$4250.00%
Front Row Advisors LLC 80$00.00%
Sound Income Strategies, LLC 100$2830.00%
Versant Capital Management, Inc 55$1560.00%
External links

This page lists CARA THERAPEUTICS INC's shareholders in Q2 2023. To view CARA THERAPEUTICS INC's shareholder history, click here.